Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

OCT useful to assess non ostial left main lesions

Original title: Frecuency domain optical coherente tomography to assess non-ostial left main artery. Reference: Francesco Burzotta, et al. EuroIntervention 2015;10e1-e8

 

Optical coherence tomography (OCT) has proved valuable in making decisions and monitoring stents implanted in coronary arteries, but its role in the assessment of left main (LM) lesions remains unclear.

The study included 54 patients presenting moderate to severe LM de novo lesions and bifurcation with anterior descending and circumflex ostia compromise and compared OCT to quantitative coronary angiography (QCA). 

After OCT, 26 patients (48%) received PCI, 25 (47%) medical treatment and 3 (5%) myocardial revascularization surgery. There was a good correlation between LM segment length, artefact frames, minimal lumen area and reference lumen area. The mean number of LM artefact frames was 8±10 (19%) and was more frequent at proximal and ostial level than at distal level (43.3% vs. 2.1% p<0.0001).

There was high correlation between OCT and QCA except for LM length, which was more efficient with QCA (8.4 vs. 11.6 p=0.001).

Conclusion

Study results show that OCT is feasible with good quality imaging for non ostial LM lesions. Assessment is more efficient for distal than proximal lesions.

Editorial Comment

OCT has proved to be safe and to provide quality imaging superior to IVUS, but in LM lesions this is different, since it has important technical limitations to assess ostial and proximal lesions.

To determine segment length, perhaps we should use not just one method but many, such as FFR, IVUS and even QCA. Another limitation to OCT is the need to use contrast to obtain images, especially in patients presenting compromised kidney function and renal failure.

Courtesy of Dr. Carlos Fava
Interventional Cardiologist
Favaloro Foundation 
Buenos Aires -Argentina

Carlos Fava

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...